<DOC>
	<DOCNO>NCT02109406</DOCNO>
	<brief_summary>This phase IIa dose-ranging , randomize , double-blind , chronic-dosing ( 14 Days ) , three-period , placebo-controlled , multi-center , cross-over study ass efficacy safety two dose level dual pharmacology molecule combine property long-acting muscarinic antagonist ( LAMA ) long-acting beta-agonist ( LABA ) ; ( AZD2115 ) deliver metered-dose inhaler ( MDI ) subject moderate severe chronic obstructive pulmonary disease ( COPD ) .</brief_summary>
	<brief_title>Efficacy Safety Study Two Dose Levels AZD2115 Subjects With Moderate Severe COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Chronic Obstructive Pulmonary Disease Diagnosis : Subjects establish clinical history COPD 1 year Screening , accord COPD GOLD guideline . Current former smoker history â‰¥10 pack year cigarette smoking . Postbronchodilator FEV1/FVC ratio &lt; 70 % . Prebronchodilator FEV1 must &lt; 80 % predicted Women nonchild bear potential ( ie. , physiologically incapable become pregnant , include female 2 year postmenopausal ) ; woman child bear potential , negative serum pregnancy test Screening agrees acceptable contraceptive method duration study . Pregnancy : Women pregnant lactating . Significant disease COPD , ie. , disease condition , opinion Investigator , may put subject risk participation study may influence either result study subject 's ability participate study . Primary diagnosis asthma . Alpha1 antitrypsin deficiency cause COPD Other active pulmonary disease active tuberculosis , lung cancer , bronchiectasis , sarcoidosis , idiopathic interstitial pulmonary fibrosis , primary pulmonary hypertension , uncontrolled sleep apnea . Poorly control COPD ( hospitalization due poorly control COPD within 3 month Screening require treatment corticosteroid antibiotic 6 week interval prior Screening Screening . Unstable ischemic heart disease , leave ventricular failure , document myocardial infarction within 12 month Randomization . Clinically significant abnormal ECG .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>